Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL-ENIGMA study explored the effect of Souvenaid on synapse function in early AD by asses...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Alzheimers Dement (N Y)
Glavni autori: Scheltens, Nienke M.E., Briels, Casper T., Yaqub, Maqsood, Barkhof, Frederik, Boellaard, Ronald, van der Flier, Wiesje M., Schwarte, Lothar A., Teunissen, Charlotte E., Attali, Amos, Broersen, Laus M., van Berckel, Bart N.M., Scheltens, Philip
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Featured Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://ncbi.nlm.nih.gov/pubmed/31650005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.08.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items